E- ISSN: 3023-6215
Severe COVID-19 Pneumonia and Critical Congenital Heart Disease in a Newborn [Anatol J Med ]
Anatol J Med . 2023; 33(1): 142-145 | DOI: 10.4274/terh.galenos.2021.93653

Severe COVID-19 Pneumonia and Critical Congenital Heart Disease in a Newborn

Osman Güvenç1, Serdar Başgöze2, Serdar Beken3, Metehan Özen4, Ender Ödemiş1
1Acıbadem University Faculty of Medicine, Department of Pediatric Cardiology, İstanbul, Turkey
2Acıbadem University Faculty of Medicine, Department of Pediatric Cardiovascular Surgery, İstanbul, Turkey
3Acıbadem University Faculty of Medicine, Department of Neonathology, İstanbul, Turkey
4Acıbadem University Faculty of Medicine, Department of Pediatric Infectious Disease, İstanbul, Turkey

The new coronavirus infection, which has resulted in a pandemic, may lead to pneumonia, severe respiratory insufficiency, multi-organ failure, and death in adults and elderly as well as people with chronic diseases. As the number of people affected by this globall pandemic, patients in all age groups are being identified with more reported neonatal and pediatric patients. It has been reported that neonates and infants with a congenital cardiac disease constitute the most commonly affected group. Favipiravir may be administered in case of coronavirus disease-2019 (COVID-19) pneumonia that starts in the neonatal period. Here, we report a newborn with an interrupted aortic arch and severe COVID-19 pneumonia. The patient, who had severe COVID pneumonia, was successfully operated after being treated.

Keywords: COVID-19, pneumonia, newborn, interrupted aortic arch, favipiravir

Corresponding Author: Osman Güvenç, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE
 (26 accesses)
 (355 downloaded)
LookUs & Online Makale